Structured Review

GenXPro Inc rapid mace kit
Rapid Mace Kit, supplied by GenXPro Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rapid mace kit/product/GenXPro Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
rapid mace kit - by Bioz Stars, 2024-07
86/100 stars

Images


Structured Review

GenXPro Inc rapid mace kit
Rapid Mace Kit, supplied by GenXPro Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rapid mace kit/product/GenXPro Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
rapid mace kit - by Bioz Stars, 2024-07
86/100 stars

Images


Structured Review

GenXPro Inc rapid mace seq kit
a) Schematic drawing of the experimental setup. <t>MACE-seq</t> was performed on samples from brain-like ECs (in co-culture with PCs), with or without 48 <t>h</t> <t>cARLA</t> treatment. b) Principal component analysis (PCA) plot of control and cARLA samples. c) Venn-diagram showing the number of genes upregulated (log 2 FC ≥ 0.2 and FDR < 0.01), downregulated (log 2 FC ≥ -0.2 and FDR < 0.01) or not changed (|log 2 FC| < 0.2 and/or FDR ≥ 0.01) upon cARLA treatment. Log 2 FC: log 2 (fold change), FDR: false discovery rate. d) Mean-difference (MD) plot presenting the range and distribution of all transcripts (circles) regarding their mean expression and log 2 FC upon cARLA treatment. Key transcripts related to different aspects of BBB function are highlighted. e) Functional enrichment analysis of up- and downregulated gene sets upon cARLA treatment using g:Profiler. Gene Ontology Biological Process (GO:BP) terms are ranked based on their gene ratio (the fraction of differentially expressed genes in a given term) and are colored based on statistical significance (FDR). f) Representative staining of F-actin (grey), with or without cARLA treatment. Nuclei were stained with Hoechst (blue). Bar: 40 µm. g) Validation of the definitive endothelial nature of human stem cell-derived brain-like ECs. Normalized counts of key epithelial and endothelial transcripts from our dataset are plotted on a 3-segment y-axis covering multiple orders of magnitude. h) Scaled heatmap of 92 transcripts that are enriched in mouse brain ECs and are well expressed at the human BBB. Genes upregulated, downregulated or not changed upon cARLA treatment as well as genes not expressed (normalized counts ≤ 1) in this model are shown separately, in alphabetical order. Color coding represents row z-scores after Min-Max normalization, the darkest color corresponding to the highest expression in a given row.
Rapid Mace Seq Kit, supplied by GenXPro Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rapid mace seq kit/product/GenXPro Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
rapid mace seq kit - by Bioz Stars, 2024-07
86/100 stars

Images

1) Product Images from "A small molecule cocktail for robust induction of blood-brain barrier properties"

Article Title: A small molecule cocktail for robust induction of blood-brain barrier properties

Journal: bioRxiv

doi: 10.1101/2023.02.09.527899

a) Schematic drawing of the experimental setup. MACE-seq was performed on samples from brain-like ECs (in co-culture with PCs), with or without 48 h cARLA treatment. b) Principal component analysis (PCA) plot of control and cARLA samples. c) Venn-diagram showing the number of genes upregulated (log 2 FC ≥ 0.2 and FDR < 0.01), downregulated (log 2 FC ≥ -0.2 and FDR < 0.01) or not changed (|log 2 FC| < 0.2 and/or FDR ≥ 0.01) upon cARLA treatment. Log 2 FC: log 2 (fold change), FDR: false discovery rate. d) Mean-difference (MD) plot presenting the range and distribution of all transcripts (circles) regarding their mean expression and log 2 FC upon cARLA treatment. Key transcripts related to different aspects of BBB function are highlighted. e) Functional enrichment analysis of up- and downregulated gene sets upon cARLA treatment using g:Profiler. Gene Ontology Biological Process (GO:BP) terms are ranked based on their gene ratio (the fraction of differentially expressed genes in a given term) and are colored based on statistical significance (FDR). f) Representative staining of F-actin (grey), with or without cARLA treatment. Nuclei were stained with Hoechst (blue). Bar: 40 µm. g) Validation of the definitive endothelial nature of human stem cell-derived brain-like ECs. Normalized counts of key epithelial and endothelial transcripts from our dataset are plotted on a 3-segment y-axis covering multiple orders of magnitude. h) Scaled heatmap of 92 transcripts that are enriched in mouse brain ECs and are well expressed at the human BBB. Genes upregulated, downregulated or not changed upon cARLA treatment as well as genes not expressed (normalized counts ≤ 1) in this model are shown separately, in alphabetical order. Color coding represents row z-scores after Min-Max normalization, the darkest color corresponding to the highest expression in a given row.
Figure Legend Snippet: a) Schematic drawing of the experimental setup. MACE-seq was performed on samples from brain-like ECs (in co-culture with PCs), with or without 48 h cARLA treatment. b) Principal component analysis (PCA) plot of control and cARLA samples. c) Venn-diagram showing the number of genes upregulated (log 2 FC ≥ 0.2 and FDR < 0.01), downregulated (log 2 FC ≥ -0.2 and FDR < 0.01) or not changed (|log 2 FC| < 0.2 and/or FDR ≥ 0.01) upon cARLA treatment. Log 2 FC: log 2 (fold change), FDR: false discovery rate. d) Mean-difference (MD) plot presenting the range and distribution of all transcripts (circles) regarding their mean expression and log 2 FC upon cARLA treatment. Key transcripts related to different aspects of BBB function are highlighted. e) Functional enrichment analysis of up- and downregulated gene sets upon cARLA treatment using g:Profiler. Gene Ontology Biological Process (GO:BP) terms are ranked based on their gene ratio (the fraction of differentially expressed genes in a given term) and are colored based on statistical significance (FDR). f) Representative staining of F-actin (grey), with or without cARLA treatment. Nuclei were stained with Hoechst (blue). Bar: 40 µm. g) Validation of the definitive endothelial nature of human stem cell-derived brain-like ECs. Normalized counts of key epithelial and endothelial transcripts from our dataset are plotted on a 3-segment y-axis covering multiple orders of magnitude. h) Scaled heatmap of 92 transcripts that are enriched in mouse brain ECs and are well expressed at the human BBB. Genes upregulated, downregulated or not changed upon cARLA treatment as well as genes not expressed (normalized counts ≤ 1) in this model are shown separately, in alphabetical order. Color coding represents row z-scores after Min-Max normalization, the darkest color corresponding to the highest expression in a given row.

Techniques Used: Co-Culture Assay, Expressing, Functional Assay, Staining, Derivative Assay

Gene expressional changes after 48 h cARLA treatment were determined using MACE-seq profiling and are presented in panels a-i) by category. Mean ± SD, n =4. Red and blue color indicates up- and downregulation, respectively, upon cARLA treatment.
Figure Legend Snippet: Gene expressional changes after 48 h cARLA treatment were determined using MACE-seq profiling and are presented in panels a-i) by category. Mean ± SD, n =4. Red and blue color indicates up- and downregulation, respectively, upon cARLA treatment.

Techniques Used:


Structured Review

GenXPro Inc rapid mace kit
Rapid Mace Kit, supplied by GenXPro Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rapid mace kit/product/GenXPro Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
rapid mace kit - by Bioz Stars, 2024-07
86/100 stars

Images


Structured Review

GenXPro Inc rapid mace seq kit
Rapid Mace Seq Kit, supplied by GenXPro Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rapid mace seq kit/product/GenXPro Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
rapid mace seq kit - by Bioz Stars, 2024-07
86/100 stars

Images

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    GenXPro Inc rapid mace kit
    Rapid Mace Kit, supplied by GenXPro Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rapid mace kit/product/GenXPro Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rapid mace kit - by Bioz Stars, 2024-07
    86/100 stars
      Buy from Supplier

    86
    GenXPro Inc rapid mace seq kit
    a) Schematic drawing of the experimental setup. <t>MACE-seq</t> was performed on samples from brain-like ECs (in co-culture with PCs), with or without 48 <t>h</t> <t>cARLA</t> treatment. b) Principal component analysis (PCA) plot of control and cARLA samples. c) Venn-diagram showing the number of genes upregulated (log 2 FC ≥ 0.2 and FDR < 0.01), downregulated (log 2 FC ≥ -0.2 and FDR < 0.01) or not changed (|log 2 FC| < 0.2 and/or FDR ≥ 0.01) upon cARLA treatment. Log 2 FC: log 2 (fold change), FDR: false discovery rate. d) Mean-difference (MD) plot presenting the range and distribution of all transcripts (circles) regarding their mean expression and log 2 FC upon cARLA treatment. Key transcripts related to different aspects of BBB function are highlighted. e) Functional enrichment analysis of up- and downregulated gene sets upon cARLA treatment using g:Profiler. Gene Ontology Biological Process (GO:BP) terms are ranked based on their gene ratio (the fraction of differentially expressed genes in a given term) and are colored based on statistical significance (FDR). f) Representative staining of F-actin (grey), with or without cARLA treatment. Nuclei were stained with Hoechst (blue). Bar: 40 µm. g) Validation of the definitive endothelial nature of human stem cell-derived brain-like ECs. Normalized counts of key epithelial and endothelial transcripts from our dataset are plotted on a 3-segment y-axis covering multiple orders of magnitude. h) Scaled heatmap of 92 transcripts that are enriched in mouse brain ECs and are well expressed at the human BBB. Genes upregulated, downregulated or not changed upon cARLA treatment as well as genes not expressed (normalized counts ≤ 1) in this model are shown separately, in alphabetical order. Color coding represents row z-scores after Min-Max normalization, the darkest color corresponding to the highest expression in a given row.
    Rapid Mace Seq Kit, supplied by GenXPro Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rapid mace seq kit/product/GenXPro Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rapid mace seq kit - by Bioz Stars, 2024-07
    86/100 stars
      Buy from Supplier

    Image Search Results


    a) Schematic drawing of the experimental setup. MACE-seq was performed on samples from brain-like ECs (in co-culture with PCs), with or without 48 h cARLA treatment. b) Principal component analysis (PCA) plot of control and cARLA samples. c) Venn-diagram showing the number of genes upregulated (log 2 FC ≥ 0.2 and FDR < 0.01), downregulated (log 2 FC ≥ -0.2 and FDR < 0.01) or not changed (|log 2 FC| < 0.2 and/or FDR ≥ 0.01) upon cARLA treatment. Log 2 FC: log 2 (fold change), FDR: false discovery rate. d) Mean-difference (MD) plot presenting the range and distribution of all transcripts (circles) regarding their mean expression and log 2 FC upon cARLA treatment. Key transcripts related to different aspects of BBB function are highlighted. e) Functional enrichment analysis of up- and downregulated gene sets upon cARLA treatment using g:Profiler. Gene Ontology Biological Process (GO:BP) terms are ranked based on their gene ratio (the fraction of differentially expressed genes in a given term) and are colored based on statistical significance (FDR). f) Representative staining of F-actin (grey), with or without cARLA treatment. Nuclei were stained with Hoechst (blue). Bar: 40 µm. g) Validation of the definitive endothelial nature of human stem cell-derived brain-like ECs. Normalized counts of key epithelial and endothelial transcripts from our dataset are plotted on a 3-segment y-axis covering multiple orders of magnitude. h) Scaled heatmap of 92 transcripts that are enriched in mouse brain ECs and are well expressed at the human BBB. Genes upregulated, downregulated or not changed upon cARLA treatment as well as genes not expressed (normalized counts ≤ 1) in this model are shown separately, in alphabetical order. Color coding represents row z-scores after Min-Max normalization, the darkest color corresponding to the highest expression in a given row.

    Journal: bioRxiv

    Article Title: A small molecule cocktail for robust induction of blood-brain barrier properties

    doi: 10.1101/2023.02.09.527899

    Figure Lengend Snippet: a) Schematic drawing of the experimental setup. MACE-seq was performed on samples from brain-like ECs (in co-culture with PCs), with or without 48 h cARLA treatment. b) Principal component analysis (PCA) plot of control and cARLA samples. c) Venn-diagram showing the number of genes upregulated (log 2 FC ≥ 0.2 and FDR < 0.01), downregulated (log 2 FC ≥ -0.2 and FDR < 0.01) or not changed (|log 2 FC| < 0.2 and/or FDR ≥ 0.01) upon cARLA treatment. Log 2 FC: log 2 (fold change), FDR: false discovery rate. d) Mean-difference (MD) plot presenting the range and distribution of all transcripts (circles) regarding their mean expression and log 2 FC upon cARLA treatment. Key transcripts related to different aspects of BBB function are highlighted. e) Functional enrichment analysis of up- and downregulated gene sets upon cARLA treatment using g:Profiler. Gene Ontology Biological Process (GO:BP) terms are ranked based on their gene ratio (the fraction of differentially expressed genes in a given term) and are colored based on statistical significance (FDR). f) Representative staining of F-actin (grey), with or without cARLA treatment. Nuclei were stained with Hoechst (blue). Bar: 40 µm. g) Validation of the definitive endothelial nature of human stem cell-derived brain-like ECs. Normalized counts of key epithelial and endothelial transcripts from our dataset are plotted on a 3-segment y-axis covering multiple orders of magnitude. h) Scaled heatmap of 92 transcripts that are enriched in mouse brain ECs and are well expressed at the human BBB. Genes upregulated, downregulated or not changed upon cARLA treatment as well as genes not expressed (normalized counts ≤ 1) in this model are shown separately, in alphabetical order. Color coding represents row z-scores after Min-Max normalization, the darkest color corresponding to the highest expression in a given row.

    Article Snippet: A total of 8 libraries (4 control and 4 cARLA) were constructed using the Rapid MACE-Seq kit (GenXPro GmbH, Frankfurt, Germany) according to the manufacturer’s protocol.

    Techniques: Co-Culture Assay, Expressing, Functional Assay, Staining, Derivative Assay

    Gene expressional changes after 48 h cARLA treatment were determined using MACE-seq profiling and are presented in panels a-i) by category. Mean ± SD, n =4. Red and blue color indicates up- and downregulation, respectively, upon cARLA treatment.

    Journal: bioRxiv

    Article Title: A small molecule cocktail for robust induction of blood-brain barrier properties

    doi: 10.1101/2023.02.09.527899

    Figure Lengend Snippet: Gene expressional changes after 48 h cARLA treatment were determined using MACE-seq profiling and are presented in panels a-i) by category. Mean ± SD, n =4. Red and blue color indicates up- and downregulation, respectively, upon cARLA treatment.

    Article Snippet: A total of 8 libraries (4 control and 4 cARLA) were constructed using the Rapid MACE-Seq kit (GenXPro GmbH, Frankfurt, Germany) according to the manufacturer’s protocol.

    Techniques: